Pages
Bellwether Vioxx trial
by
Sep 1, 2007
Opening arguments are scheduled today in the case of two men who each took Vioxx for more than two years and claim they suffered a heart attack as a result. Helen Palmer reports that the outcome of this trial could well determine the viability of other liability cases against the drug's maker, Merck.
Celebrex study
by
Sep 1, 2007
We've all heard the charges that Vioxx can trigger heart attacks. Now comes word that rival pain reliever Celebrex may also exacerbate heart problems. Helen Palmer reports.
Ban on French birds
by
Sep 1, 2007
The threat of bird flu has caused the US to ban some poultry and live bird shipments from France. Helen Palmer reports on the fallout.
Rising health costs hurt hospitals
by
Sep 1, 2007
A new study out shows high healthcare costs have left most hospitals in Southern California in the red. As Helen Palmers reports, healthcare facilities across the country face a similar bind.
As parents work, children suffer
by
Sep 1, 2007
A comprehensive study finds increasing numbers of working parents around the globe don't have enough time off to care for ailing children. From the Work and Family Desk, Hillary Wicai has more.
Bird flu summit
by
Sep 1, 2007
Bird flu experts from around the world assemble in Washington today to discuss how businesses can prepare for a possible outbreak. Eric Niiler reports.
Flonase injunction
by
Sep 1, 2007
A federal judge in Maryland has granted Glaxo Smith Kline's request for an injunction. The British company wants to stop sales of a generic version of its best-selling allergy drug Flonase. Generic drug makers want a piece of the $1.2 billion dollars Flonase brings in each year. And they say Big Pharma's using hard-ball tactics to shut them out. Helen Palmer reports from the Health Desk at WGBH.
The smoking lounge is open
by
Sep 1, 2007
Cities across the US, including New York and Los Angeles, have banned smoking in restaurants and even bars. Chicago finally caved into that peer pressure last month... perfect timing for the city's new luxury smoking lounge. Diantha Parker reports.
Dr. Wal-Mart
by
Sep 1, 2007
Wal-Mart will be expanding its health insurance program, covering the children of part-timers and reducing the waiting period for coverage eligibility. They'll also be opening cheap clinics in some stores. As Stacey Vanek-Smith reports, businesses across the US are watching.
Glaxo defends Flonase
by
Sep 1, 2007
The FDA, under fire for sluggishness in approving generic drugs, announced this week that it had OKed a generic version of the popular nasal spray Flonase. In response, the drug's maker, GlaxoSmithKline, took legal action to halt the move. Helen Palmer reports from the Health Desk at WGBH.




